Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Therapy in Amyotrophic Lateral Sclerosis (ALS) (PNA)
This study has been completed.
Study NCT00919555   Information provided by Phoenix Neurological Associates, LTD

First Received on June 8, 2009.   Last Updated on November 29, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Amyotrophic Lateral Sclerosis
Additional conditions recognized in this trial
Motor Neuron Disease
Sclerosis
More general conditions related to this trial
Central Nervous System Diseases
Metabolic Diseases
Nervous System Diseases
Neurodegenerative Diseases
Neuromuscular Diseases
Pathologic Processes
Proteostasis Deficiencies
Spinal Cord Diseases
TDP-43 Proteinopathies
Interventions listed in this trial
Pioglitazone and Tretinoin
Tretinoin and Pioglitazone HCL
Placebo
Additional drug interventions recognized in this trial
Pioglitazone
Tretinoin
More general drug interventions related to this trial
Antineoplastic Agents
Dermatologic Agents
Hypoglycemic Agents
Keratolytic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Phoenix Neurological Associates, LTD


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services